Endocannabinoids at the Synapse a Decade After the Dies Mirabilis (29 March 2001): What We Still Do Not Know
Overview
Authors
Affiliations
Endogenous cannabinoids (endocannabinoids, eCBs) are ubiquitous regulators of synaptic transmission in the brain, mediating numerous forms of short- and long-term plasticity, and having strong influences on synapse formation and neurogenesis. Their roles as retrograde messengers that suppress both excitatory and inhibitory transmission are well-established. Yet, despite intensive investigation, many basic aspects of the eCB system are not understood. This brief review highlights recent advances, problems that remain unresolved, and avenues for future exploration. While 2-arachidonoylglycerol (2-AG) is probably the major eCB for intercellular CB1R-dependent signalling, anandamide (AEA) has come to the forefront in several novel contexts, both as a dual endovanilloid/endocannabinoid that regulates synaptic transmission acutely and as the source of a steady eCB tone in hippocampus. Complexities in the cellular processing of 2-AG are receiving renewed attention, as they are increasingly recognized as major determinants of how 2-AG affects cells. Long-standing fundamental issues such as the synthesis pathway for AEA and the molecular mechanism(s) underlying cellular uptake and release of eCBs remain problematical.
Impacts of hnRNP A1 Splicing Inhibition on the Brain Remyelination Proteome.
Brandao-Teles C, Carregari V, Reis-de-Oliveira G, Smith B, Chaves Y, Sousa Santos A J Neurochem. 2025; 169(1):e16304.
PMID: 39840781 PMC: 11752419. DOI: 10.1111/jnc.16304.
Cannabis, Endocannabinoids and Brain Development: From Embryogenesis to Adolescence.
Rodrigues R, Marques J, Kofalvi A Cells. 2024; 13(22).
PMID: 39594623 PMC: 11593331. DOI: 10.3390/cells13221875.
Briand-Mesange F, Gennero I, Salles J, Trudel S, Dahan L, Ausseil J Molecules. 2024; 29(15).
PMID: 39125098 PMC: 11314389. DOI: 10.3390/molecules29153694.
Dasram M, Walker R, Khamanga S Int J Mol Sci. 2022; 23(21).
PMID: 36362014 PMC: 9658826. DOI: 10.3390/ijms232113223.
Skala K, Trabi T, Fuchs M, Gossler R, Haas-Stockmair C, Kriechbaumer N Neuropsychiatr. 2022; 37(4):175-195.
PMID: 35900691 PMC: 10703949. DOI: 10.1007/s40211-022-00424-1.